Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
June 17, 2024 11:12 PM 2 min read

Palantir, Mustang Bio, DraftKings, Micron, Tesla: Why These 5 Stocks Are On Investors' Radars Today

by Benzinga Neuro Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

On Monday, major U.S. indices saw gains, with the Dow Jones Industrial Average closing nearly 0.5% higher at 38,778.10, the S&P 500 rising almost 0.8% to 5,473.23, and the Nasdaq climbing 0.95% to 17,857.02.

These are the top stocks that gained the attention of retail traders and investors throughout the day:

Palantir Technologies Inc. (NYSE:PLTR)

Palantir’s shares climbed 6.15% to close at $25.02, with an intraday high of $25.06 and a low of $22.84. The stock’s 52-week range is between $27.50 and $13.56. Argus Research’s analyst initiated coverage with a Buy rating and a $29 price target, citing expansion into the commercial sector and growth in government business as key drivers.

Mustang Bio Inc. (NASDAQ:MBIO)

See Also: As Apple, Nvidia Trade Near All-Time Highs, Jim Cramer Tells Investors To Cash In On AI Stocks: ‘Let’s Not Be Too Greedy’

DraftKings Inc. (NASDAQ:DKNG)

DraftKings saw its shares increase by 7.81% to end the day at $41.95, with an intraday high of $42.21 and a low of $38.93. The stock’s 52-week high is $49.57, with a low of $24.16. The surge came after the U.S. Supreme Court’s decision impacting online sports betting in Florida and tax optimism in New Jersey.

Micron Technology Inc. (NASDAQ:MU)

Micron’s stock rose 4.58% to $147.83, with a high of $148.75 and a low of $142.14 on the day. The 52-week high is $148.75, and the low is $60.50. Analysts from BofA Securities and Susquehanna maintained positive ratings and raised price targets ahead of the company’s third-quarter financial results.

Tesla Inc. (NASDAQ:TSLA)

Image via Shutterstock.

Prepare for the day’s trading with top premarket movers and news by Benzinga.

Read Next: Trump’s Birthday Speech On Tax Cuts, Immigrants Raises Eyebrows: ‘Our Country Has Never Been In Danger Like It Is In Danger Right Now’

This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EquitiesNewsMarketsGeneralelectric vehiclesElon MuskEVsPalantir TechnologiesShivdeep DhaliwalTesla
DKNG Logo
DKNGDraftKings Inc
$25.31-%
Overview
MBIO Logo
MBIOMustang Bio Inc
$1.02-%
MU Logo
MUMicron Technology Inc
$411.45-%
PLTR Logo
PLTRPalantir Technologies Inc
$152.35-%
TSLA Logo
TSLATesla Inc
$406.83-%

Mustang Bio’s stock skyrocketed by 476.92%, closing at $0.75, after reaching an intraday peak of $0.97 and a low of $0.29. The 52-week range has been $8.17 to $0.13. The shares soared after the company announced safety and efficacy data from the complete Waldenstrom Macroglobulinemia cohort of its Phase 1/2 clinical trial of MB-106, showing a 90% overall response rate with one patient remaining in complete remission at 31 months.

Tesla’s shares advanced 5.30%, closing at $187.44. The stock hit a high of $188.81 and a low of $177.00 during the session, with a 52-week range of $299.29 to $138.80. Shareholders recently approved a $44 billion pay package for CEO Elon Musk and voted on other significant corporate decisions.

DKNG Logo
DKNGDraftKings Inc
$25.31-%
Overview
MBIO Logo
MBIOMustang Bio Inc
$1.02-%
MU Logo
MUMicron Technology Inc
$411.45-%
PLTR Logo
PLTRPalantir Technologies Inc
$152.35-%
TSLA Logo
TSLATesla Inc
$406.83-%
Comments
Loading...